Vitamin D During Hormone Therapy for Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether taking vitamin D while you are on prostate hormone therapy (ADT) affects your health outcomes. It may help by keeping vitamin D levels in a safe range during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer from Stage I to Stage IV, but it has not spread to your bones
- You are age 50 or older
- You are starting ADT (hormone therapy) or got your first ADT dose within the last 6 months, and you plan to be on it at least 6 months
- Your blood tests show vitamin D between 10 and 32 ng/mL, and calcium is 10.5 mg/dL or lower
- You have kidney function that is normal for the trial (GFR over 30 mL/min), and you can swallow pills
- You agree not to take extra vitamin D or calcium supplements beyond what the study provides
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether your blood vitamin D level is linked to hormone-related side effects caused by immune checkpoint cancer drugs. It may help doctors better predict who is at risk and how to monitor patients during treatment.
This trial tests a short course of hormone therapy (androgen deprivation therapy) for men with a certain type of prostate cancer that is considered high-risk. The goal is to see if a shorter treatment period can still control the cancer while reducing side effects.
This trial tests an experimental vaccine (2141-V11) combined with standard hormone therapy and an anti-androgen drug before prostate removal surgery. It aims to see if the combination can help the immune system fight the cancer more effectively.
This trial tests whether taking vitamin D for 8 weeks can improve immune function in Black or West African men with prostate cancer. It compares effects in men with localized cancer versus those whose cancer has spread.
This study looks at how certain hormone treatments for prostate cancer might affect bone strength over time. It aims to help doctors understand how to protect bones in men with prostate cancer that has spread.
This early-phase study looks at how vitamin D replacement affects the immune system in Black/African American men with prostate cancer. It’s testing whether bringing vitamin D levels into a healthier range changes immune signals that may matter for cancer health.
Hear when a new Stage I Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.